Flash Sell: Book 250% Gains Right Now

By Ray BlancoPosted February 21, 2020

Space tourism hit a new milestone. A new space ship is ready for testing in the Mojave desert. And your open position has gone parabolic. Let’s grab these gains while we still can…

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

Ray Blanco’s VIP Tech Advantage

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, Ray Blanco’s FDA Trader, Penny Pot Profits, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

In the Midst of Market Mayhem, Prospects for Solid Biotech Growth and Profits

By Ray BlancoPosted April 11, 2014

It's easy to forget that despite the current state of the markets in general, and biotechnology stocks in particular, many small biotechs are still moving their products from the lab and clinic to the market. In the biotech world, this is the road to profitability and share appreciation over time.

Isis Scores Historic First in Treating Genetic Disease

By Ray BlancoPosted February 1, 2013

After many years of dogged research and development effort, Isis Pharmaceuticals has finally done it. This week, the company's efforts achieved success with an FDA approval for what will be the world's first commercial systemic antisense therapy. The compound, mipomersen, will be marketed under the name Kynamro. It is designed to treat patients with familial hypercholesterolemia (FH), a serious genetic disorder, by blocking the gene that codes for apoliprotein B, which is abnormal in individuals with FH. Individuals with two abnormal copies of the gene -- which causes high levels of LDL cholesterol -- will now have a new treatment option.

Profiting from Information Overload

By Ray BlancoPosted November 12, 2010

Throughout most of history, human beings could expect to grow old and die in a world very much like the one into which they were born. History has since changed. Technologic change is growing ever faster and that's where our opportunity to profit rests...

Big News for Your COVID-19 Position

By Ray BlancoPosted June 25, 2020

One of our positions just got a huge monetary boost from the DoD. And the market loves it, sending shares up almost 100% in a week. We await to see what happens next with the first round of clinical data.

Bye, Jeff! How the Marijuana Market Won Big This Week

By Ray BlancoPosted November 9, 2018

Many states made strides in legalizing marijuana on election night, and marijuana is now legal in some form in 33 states. But that wasn’t the only big news around cannabis to come out this week…

Our Cybersecurity Play Bounces Back

By Ray BlancoPosted June 2, 2017

Data collection is ballooning at an incredible rate with no end in sight. We're storing data because it is valuable… but that makes it valuable for thieves, too. This company's network security products are some of the most advanced in the cybersecurity industry…

Login